References
Arbesman, C. E., E. Neter, andC. F. Becker: The effect of pyribenzamine, neohetramine, and rutin on reversed anaphylaxis in guinea pigs. J. Allergy21, 25–33 (1950).
Becker, E. L.: Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl-fluorophosphate. II. The nature of the first component of guinea pig complement. J. Immunology77, 462–468, 469–478 (1956).
Becker, E. L.: In vitro models for the allergic reaction. In: Mechanisms of hypersensitivity, ed. byJ. H. Shaffer, G. A. Lo Grippo andM. W. Chase, p. 305–315. Boston 1959.
Becker, E. L.: The possible significance of a particular group of serine esterases in pathological permeability changes. In: Mechanisms of cell and tissue damage produced by immune reactions, p. 37–50. Basel 1962.
Bodammer, G., andW. Vogt: Int. Arch. Allergy. In preparation (1967).
Bordet, J.: Le mécanisme de l'anaphylaxie. C.R. Soc. Biol. (Paris)74, 225–227 (1913).
Conard, V., andW. Mutsaars: Effet antagoniste des colorants basiques sur la genèse de l' “Anaphylatoxine”. C.R. Soc. Biol. (Paris)143, 129–130 (1949).
Cremona, T., andT. P. Singer: Non-dissociability of the metal component of D-α-hydroxy acid dehydrogenase by chelating agents. Nature (Lond.)194, 836 (1962).
Dale, H. H.: The anaphylactic reaction of plain muscle in the guinea pig. J. Pharmacol. exp. Ther.4, 167–223 (1913).
Ferluga, J.: Die Wirkung des, durch Polysaccharide aktivierten Rattenblutserums auf den isolierten Darm und Uterus der Ratte. Allergie u. Asthma6, 229–232 (1960).
Frick, O. L., B. N. Halpern, andP. Liacopoulos: The mechanism of protection from anaphylactic shock in the guinea-pig by pre-treatment with anaphylatoxin. J. Physiol. (Lond.)163, 191–199 (1962).
Friedberg, K. D., u.U. Bauer: Anaphylaktischer Schock nach passiver Sensibilisierung am anaphylatoxinvorbehandelten, Meerschweinchen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.250, 171–172 (1965).
—,G. Engelhardt u.F. Meineke: Untersuchungen über die Anaphylatoxin-Tachyphylaxie und über ihre Bedeutung für den Ablauf echter anaphylaktischer Reaktionen. Int. Arch. Allergy25, 154–181 (1964).
Friedberger, E.: Weitere Untersuchungen über Eiweißanaphylaxie. IV. Mitt. Z. Immun.-Forsch.4, 636–689 (1910).
Gaddum, J. H.: Discussion. In: Polypeptides which stimulate plain muscle, ed. byJ. H. Gaddum, p. 130–136. Edinburgh 1955.
Giertz, H., u.F. Hahn: Über die Reaktionsbedingungen der Anaphylatoxinbildung. Naturwissenschaften44, 467 (1957).
——: Weitere Untersuchungen über die Bildung und die Natur des Anaphylatoxins. Int. Arch. Allergy19, 94–111 (1961).
——: Makromolekulare Histaminliberatoren. C. Das Anaphylatoxin. In: Heffters Handbuch der Pharmakologie, Erg.-Band 18/1, S. 517–545. Springer: Berlin-Heidelberg-New York 1966.
——,I. Jurna u.A. Lange: Zur Frage der Beteiligung des Anaphylatoxins im anaphylaktischen Schock. Int. Arch. Allergy13, 201–212 (1958).
——: u.A. Lange: Über die Natur und Bildung von Rattenserumanaphylatoxin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.229, 366–373 (1956).
Greeff, K., B. G. Benfey u.A. Bokelmann: Anaphylaktische Reaktionen am isolierten Herzvorhofpräparat des Meerschweinchens und ihre Beeinflussung durch Antihistaminica, BOL, Dihydroergotamin und Reserpin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.236, 421–434 (1959).
Hahn, F., u.A. Lange: Versuche zur Isolierung von Rattenserum-Anaphylatoxin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.227, 12–22 (1955).
—, u.A. Oberdorf: Antihistaminica und anaphylaktoide Reaktionen. Z. Immun.-Forsch.107, 528–538 (1950).
Haining, C. G.: Histamine release in rabbit blood by dextran and dextran sulphate. Brit. J. Pharmacol.10, 87–94 (1955).
—: Activation of rabbit serum protease by dextran sulphate Brit. J. Pharmacol.11, 107–110 (1956a).
—: Inhibition of histamine release by sodium salicylate and other compounds. Brit. J. Pharmacol.11, 357–363 (1956b).
Halpern, B. N., etP. Liacopoulos: Protection du cobaye contre le choc anaphylactique mortel par l-anaphylatoxine et son mécanisme. C. R. Soc. Biol. (Paris)150, 108–112 (1956).
Jobling, J. W., andW. Petersen: The mechanism of anaphylatoxin formation. Studies on ferment action. XV. J. exp. Med.20, 37–51 (1914).
Jones, J. H.: Studies on the activation of anaphylatoxin. Int. Arch. Allergy17, 99–105 (1960).
Kabat, E. A., andM. M. Mayer: Experimental immunochemistry, 2nd ed. Springfield 1961.
Kumagai, T.: Über Anaphylaxie. XXXVI. Mitt. Die Lungenblähung bei der Anaphylatoxinvergiftung und bei einigen ähnlich wirkenden Giften. Z. Immun.-Forsch.17, 607–638 (1913).
Lyncker, J., u.W. Vogt: Differenzierung zwischen dem pyrogenbildenden und dem anaphylatoxinbildenden System in Plasma. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.253, 71 (1966).
Marquardt, P., u.L. Hedler: Anaphylatoxin und DAS (“Frühgift”). Arzneimittel-Forsch.15, 1261–1265 (1965).
Mota, I.: Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats. Brit. J. Pharmacol.12, 453–456 (1957).
—: The mechanism of action of anaphylatoxin. Its effect on guinea pig mast cells. Immunology2, 403–413 (1959).
Moussatché, H., andA. P. Danon: Inhibition by sulfhydril blocking agents of the guinea-pig gut reaction to anaphylaxis and to anaphylatoxin. Naturwissenschaften43, 227 (1956).
Murata, Y., M. Satake, andT. Suzuki Studies on snake venom. XII. Distribution of proteinase activities among Japanese and Formosan snake venoms. J. Biochem. (Tokyo)53, 431–437 (1963).
Netzer, W., u.W. Vogt: Anaphylatoxinbildung durch pyrogenes Lipopolysaccharid. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.248, 261–268 (1964).
Osler, A. G., H. G. Randall, B. M. Hill, andZ. Ovary: Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin. J. exp. Med.110, 311–339 (1959).
Randall, H. G., S. L. Talbot, H. C. Neu, andA. G. Osler: Studies on the mechanism of hypersensitivity phenomena. IV. An isometric smooth muscle assay system. Immunology4, 388–400 (1961).
Ritz, H., u.H. Sachs: Über das Anaphylatoxin. Berl. klin. Wschr.48, 987–992 (1911).
Rocha e Silva, M.: Activation by polysaccharides of a histamine liberator (anaphylatoxin) in blood plasma. In: Symposium on the mechanism of inflammation, p. 325–334. Montreal 1953.
—: Anaphylatoxin and histamine release. Quart. Rev. Allergy8, 220–238 (1954).
—, andM. Aronson: Histamine release from the perfused lung of the guinea pig by serotoxin (anaphylatoxin). Brit. J. exp. Path.33, 577–586 (1952).
—, andA. M. Rothschild: Experimental design for bioassay of a material inducing strong tachyphylactic effect (anaphylatoxin). Brit. J. Pharmacol.11, 252–262 (1956).
Rothschild, A. M., andM. Rocha e Silva: Activation of a histamine-releasing agent (anaphylatoxin) in normal rat plasma. Brit. J. exp. Path.35, 507–518 (1954).
Schultz, W. H.: Physiological studies in anaphylaxis. I. The reaction of smooth muscle of the guinea-pig sensitized with horse serum. J. Pharmacol. exp. Ther.1, 549–567 (1910).
Schwoerer, D.: Untersuchungen über das Vorkommen des anaphylatoxinbildenden Systems im Plasma verschiedener Tierarten. Thesis Göttingen 1966.
Stegemann, H., G. Bernhard u.J. A. O'Neil: Endgruppen von Anaphylatoxin. Einfache Sequenzanalyse von carboxyl-endständigen Aminosäuren. Hoppe-Seylers Z. physiol. Chem.339, 9–13 (1964).
—,R. Hillebrecht u.W. Rien: Zur Chemie des Anaphylatoxins. Hoppe-Seylers Z. physiol. Chem.340, 11–17 (1965).
—,W. Vogt u.K. D. Friedberg: Über die Natur, des Anaphylatoxins. Hoppe-Seylers Z. physiol. Chem.337, 269–276 (1964).
Tu, A. T., R. B. Passey, andT. Tu: Proteolytic enzyme activities of snake venoms. Toxicon4, 59–60 (1966).
Ungar, G., T. Yamura, J. B. Isola, andJ. B. Isola, andS. Kobrin: Further studies on the role of proteases in the allergic reaction. J. exp. Med.113, 359–380 (1961).
Vaughan, V. C., andS. M. Wheeler: The effects of egg-white and its split products on animals; a study of susceptibility and immunity. J. infect. Dis.,4, 476–508 (1907).
Vogt, W.: Anaphylatoxinbildung durch ein Metallferment. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.246, 31–32 (1963).
—: Weitere Untersuchungen zur Fermentnatur der Anaphylatoxinentstehung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.247, 327 (1964).
—, u.G. Schmidt: Abtrennung des anaphylatoxinbildenden Prinzips aus Cobragift von anderen Giftkomponenten. Experientia (Basel)20, 207–208 (1964).
——: Einige Eigenschaften des anaphylatoxinbildenden Fermentes aus Rattenplasma. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.253, 91 (1966a).
——: Formation of anaphylatoxin in rat plasma, a specific enzymic process. Biochem. Pharmacol.15, 905–914 (1966b).
—, u.N. Zemann: Analyse der erregenden Wirkung von Anaphylatoxin auf glatte Muskulatur. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.247, 328–329 (1964).
Willems, G.: Properdine et anaphylatoxine. Revue Immunol. (Paris)27, 285–290 (1963).
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Vogt, W. The anaphylatoxin-forming system. Ergebnisse der Physiologie und exper. Pharmakologie 59, 160–184 (1967). https://doi.org/10.1007/BF02269143
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02269143